Canopy Growth Corp
CGC Nasdaq· Medicinal Chemicals & Botanical Products
Last close · Oct 30, 2026
$0.65
KIRA · Stoqly’s AI analyst, in plain words
- Canopy Growth Corp had $206M of revenue in fiscal 2026, up 6.5% on the year before. Over five years, revenue changed −13.0% a year on average.
- Its operating margin was −56.8%, down 13.3 pts: of every 100 in sales, about −57 is left after running the business.
- Canopy Growth Corp lost $190M in fiscal 2026.
- Free cash flow was −$50.0M in fiscal 2026, −24.3% of revenue. Over the last four quarters it burned $60.2M; its $236M of cash and short-term investments would last about 3.9 years at that pace.
- Canopy Growth Corp has $85.2M more cash than debt.
Market cap
$276M
P/E
—
Revenue
$206M
Net income
−$190M
Free cash flow
−$50.0M
Operating margin
−56.8%
Canopy Growth Corp in 30 seconds · fiscal 2026
Are sales growing?
+6.5%
Yes. Sales grew 6.5% last year.
Does it make a profit?
−92.4%
No. It lost money last year.
How long would its cash last?
3.9 yrs
Comfortably. It burns $60.2M a year and holds $236M, about 3.9 years at that pace.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Canopy Growth Corp does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K · Jun 15, 2026
- Legal name
- Canopy Growth Corp
- CIK
- 0001737927
Canopy Growth Corp · CGC · stoqly.net
Results and finances
The last 5 fiscal years. Amounts in USD. Compiled by stoqly.net.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $379M | $252M | $220M | $193M | $206M |
| Revenue growth | −8.2% | −33.6% | −12.5% | −12.3% | 6.5% |
| Net interest income | −$7.6M | — | — | — | — |
| Gross margin | −39.4% | −19.1% | 27.2% | 29.6% | 24.5% |
| Operating margin | −214.2% | −789.3% | −77.0% | −43.5% | −56.8% |
| Net income | −$247M | −$2.5B | −$514M | −$366M | −$190M |
| Net margin | −65.2% | −983.7% | −233.4% | −189.2% | −92.4% |
| Diluted EPS | −$6.32 | −$53.43 | −$6.87 | −$3.40 | −$0.64 |
| Cash | |||||
| Cash from operations | −$435M | −$421M | −$209M | −$119M | −$46.2M |
| Capital expenditure | $29.3M | $6.9M | $2.6M | $7.8M | $3.9M |
| Free cash flow | −$465M | −$428M | −$212M | −$127M | −$50.0M |
| FCF margin | −122.5% | −170.0% | −96.0% | −65.6% | −24.3% |
| Share count change | −89.5% | 18.5% | 61.3% | 43.8% | 177.1% |
| Debt and strength | |||||
| Cash and short-term investments | $1.1B | $571M | $150M | $91.5M | $262M |
| Debt incl. finance leases | $1.3B | $1.0B | $467M | $226M | $177M |
| Shareholders' equity | $2.9B | $560M | $295M | $333M | $501M |
| Current ratio | 8.1x | 1.3x | 1.1x | 2.9x | 3.3x |
| Interest coverage | −9.8x | −20.9x | −2.2x | −1.6x | −4.2x |
| Returns and quality | |||||
| Return on capital | −21.6% | −164.7% | −22.9% | −14.7% | −22.7% |
| Return on equity | −8.8% | −144.8% | −120.3% | −116.4% | −45.6% |
| Return on tangible equity | −20.3% | −619.5% | −275.7% | −152.1% | −48.2% |
| Piotroski F-score | 3 | 3 | 5 | 5 | 4 |
| Altman Z'' | −1.3 | −19.1 | −26.5 | −37.0 | −29.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.4M
7 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Canopy Growth Corp · CGC · stoqly.net
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.65 a share, the company is worth $276M.
Compiled and analysed by stoqly.net from SEC EDGAR XBRL filings (CIK 0001737927). Latest version: stoqly.net/companies/cgc. Data updated November 1, 2026. Filed in CAD under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.